Press Release

Printer Friendly Version View printer-friendly version
<< Back
Lubrizol LifeSciences to Highlight Complex Product Development Capabilities of Particle Sciences at 2016 AAPS Conference

    Arc_Logo_USE_10mm

 

The Lubrizol Corporation
29400 Lakeland Blvd, Wickliffe, OH 44092

Lubrizol LifeSciences to Highlight Complex Product Development Capabilities
of Particle Sciences at 2016 AAPS Conference

CLEVELAND, November 14, 2016 -The Lubrizol Corporation's LifeSciences business, a leading supplier of services and advanced materials for the pharmaceutical and medical device industry, announces it will showcase its expanded range of solutions for the pharmaceutical industry at the 2016 American Association of Pharmaceutical Scientists (AAPS) annual meeting and exposition November 14 -17 at the Colorado Convention Center in Denver, Colorado (Booth #1127).

Lubrizol LifeSciences will highlight the drug product development capabilities of Particle Sciences - a leading contract drug development and manufacturing organization with a comprehensive suite of services for the formulation, analysis and production of complex drug delivery solutions.

Lubrizol LifeSciences continues to expand its capabilities at Particle Sciences, providing full service cGMP drug product development and manufacturing across a variety of sterile and non-sterile complex dosage forms such as micro/nano-particulates, emulsions and drug-eluting devices. "With the new investment in over 2,700 ft2 of commercial cleanroom space, we continue to demonstrate our commitment to be the leading CDMO for complex drug products.  Our organization has a depth of knowledge and resources found nowhere else," stated Mark Mitchnick M.D., CEO, Particle Sciences Inc., chief medical officer, Lubrizol LifeSciences.

Lubrizol LifeSciences' newest product, Transform(TM), is the only hydrate-able topical film that offers wide API compatibility, value and convenience all in one. Transform films make loading APIs for drug delivery fast and easy. This can eliminate additional raw materials and processing steps of lamination and multiple components. Improved patient comfort is another benefit as Transform is a cool, comfortable, transparent film designed for optimal aesthetics and therapeutic benefit.

-  more  -

About Lubrizol LifeSciences
Lubrizol LifeSciences is a healthcare solution partner that provides customer support from idea to execution by supplying customizable polymers and excipients, complex drug formulation development and best-in-class contract manufacturing services for medical device and pharmaceutical manufacturers. The combination of our polymer expertise, drug formulation development and quality contract manufacturing allows LifeSciences to offer our customers end-to-end solutions for success in the drug delivery market.

About Particle Sciences
Particle Sciences, now part of Lubrizol LifeSciences, is an integrated provider of drug development and manufacturing services. Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Through a full range of formulation, analytic and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development and manufacturing solution that minimizes the time and risk between discovery and commercialization. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email info@particlesciences.com, or contact us at (610) 861- 4701 for information.

About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions. Our products for the oilfield market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world.  Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.

Particle Sciences is part of Lubrizol Advanced Materials, Inc.               

Transform(TM) is a trademark of The Lubrizol Corporation.

Media Contact
Ben Patti
(216) 447-5827
www.lubrizol.com/LifeSciences

###